跳至主要内容
临床试验/CTRI/2023/08/056093
CTRI/2023/08/056093尚未招募2 期

Evaluation Of Acute Toxicity With Intensity Modulated Moderately Hypofractionated Whole Pelvic Radiotherapy With Image Guided High Dose Rate Brachytherapy For Locally Advanced Cervical Carcinoma - NI

Dr Ram Manohar Lohia Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Histologically proven squamous carcinoma of the uterine cervix of FIGO stage IB2-IIIC1(FIGO-2018)
  • Patient being treated definitively with radiotherapy with or without concurrent chemotherapy.
  • Patient willing to sign the informed consent
  • Karnofsky Performance Status > 70
  • Normal complete blood counts, kidney and liver function tests
  • No prior chemotherapy or radiotherapy and surgery

排除标准

  • Stage other than IB2-IIIC1(FIGO2018)
  • Patients who have received neoadjuvant chemotherapy.
  • Any histopathology other than squamous cell carcinoma
  • Synchronous or metachronous malignancy
  • Pregnant or lactating women
  • Uncontrolled concurrent illness like diabetes mellitus and hypertension

研究者

发起方
Dr Ram Manohar Lohia Institute of Medical Sciences

相似试验